All Updates

All Updates

icon
Filter
Funding
Hygieia raises USD 22 million in extended Series B funding
Preventive Healthcare
May 2, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Preventive Healthcare

Preventive Healthcare

May 2, 2023

Hygieia raises USD 22 million in extended Series B funding

Funding

  • Hygieia, a virtual insulin management startup, has raised USD 22 million in its extended Series B funding round led by Firstime Ventures, with additional investment from two strategic partners.

  • The funds will be used to expand product reach to insulin users by entering new markets across the US. The company is currently building a network of diabetes care centers through a partnership program for providers treating type 2 diabetes patients.  The d-Nav Clinical Partnership Program is available in Michigan, Texas, Arizona, and North Carolina.

  • Hygieia develops d-Nav, an FDA-cleared technology that autonomously adjusts insulin dose recommendations for insulin users. The technology aims to improve A1C levels without increasing the risk of hypoglycemia. The d-Nav Insulin Management Program is covered by Medicare and several other health plans.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.